Furthermore, we revealed that SOX9 expression was significantly correlated with the serum OPN level in human cases, and that its efficacy in identifying SOX9 expression in the tumors was superior to conventional tumor markers such as AFP and PIVKA-II. This evidence concerns the gene SOX9 and neoplasm.